W. Mark Lanier says his client Carol Ernst couldn't stop crying when he told her about the 14th Court's opinion, and she told him she has lost faith in the judicial system. But Jonathan Skidmore, part of Merck's trial team in Ernst, says, "From day one, we felt there was no reliable scientific evidence that showed Mr. Ernst died due to any role that Vioxx played."
Court Reverses $26.1 Million Judgment in First Vioxx Trial
May 29, 2008
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.